Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10.1Revenue $M0.5Net Margin (%)-2,092.8Z-Score-10.6
Enterprise Value $M0.7EPS $-6.0Operating Margin %-2,555.2F-Score4
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-2,092.8Higher ROA y-yY
Price/Book0.610-y EBITDA Growth Rate %-11.1Quick Ratio3.8Cash flow > EarningsN
Price/Sales12.95-y EBITDA Growth Rate %-12.1Current Ratio5.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-87.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-150.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M5.2ROI % (ttm)-106.6Gross Margin Increase y-yY

Gurus Latest Trades with MELA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MELAGeorge Soros 2012-06-30 Sold Out -0.01%$25.1 - $47.4
($35.1)
$ 1.68-95%Sold Out0
MELAGeorge Soros 2012-03-31 Reduce-0.13%$32.1 - $48.2
($40.6)
$ 1.68-96%Reduce -80%20,000
MELAGeorge Soros 2011-12-31 Buy 0.16%$35 - $66.2
($51)
$ 1.68-97%New holding, 1000000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MELA is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MELA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DIMUN ANTHONY JDirector 2014-05-22Buy8,750$3.8-55.79 view
Coradini RobertChairman 2014-02-05Buy6,757$7.4-77.3 view
Crane Rosemary ACEO and President 2014-02-05Buy6,757$7.4-77.3 view
Swintek Kathryn BDirector 2014-02-05Buy1,351$7.4-77.3 view
Via LuAnnDirector 2014-02-05Buy1,351$7.4-77.3 view
DIMUN ANTHONY JDirector 2014-02-05Buy1,351$7.4-77.3 view
STONE DAVID KDirector 2014-02-05Buy1,351$7.4-77.3 view
ODONNELL JEFFREY FDirector 2014-02-05Buy1,351$7.4-77.3 view
Coradini RobertInterim CEO 2013-06-28Buy1,500$9.9-83.03 view
Coradini RobertInterim CEO 2013-06-27Buy1,500$8.7-80.69 view

Press Releases about MELA :

    Quarterly/Annual Reports about MELA:

    News about MELA:

    Articles On GuruFocus.com
    own Mar 20 2013 
    The Barclays Triggers More Insider Buying Mar 13 2013 
    ElectroOptical Sciences Inc Reports Operating Results (10-K) Mar 03 2011 
    ElectroOptical Sciences Inc Reports Operating Results (10-Q) Nov 05 2010 
    ElectroOptical Sciences Inc (MELA) CFO Richard I Steinhart buys 1,000 Shares Aug 12 2010 
    ElectroOptical Sciences Inc (MELA) CEO Joseph V Gulfo buys 5,000 Shares Aug 12 2010 
    ElectroOptical Sciences Inc (MELA) CEO Joseph V Gulfo buys 5,000 Shares Aug 12 2010 
    ElectroOptical Sciences Inc Reports Operating Results (10-Q) Aug 06 2010 
    ElectroOptical Sciences Inc Reports Operating Results (10-Q) May 10 2010 
    ElectroOptical Sciences Inc Reports Operating Results (10-Q) Nov 09 2009 

    More From Other Websites
    MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers Nov 19 2014
    MELA Sciences Names Michael R. Stewart Its Next President and CEO Nov 19 2014
    10-Q for MELA Sciences, Inc. Nov 18 2014
    MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report Nov 14 2014
    MELA Sciences Earnings Call scheduled for 4:30 pm ET today Nov 12 2014
    MELA Sciences Reports Third Quarter 2014 Financial Results Nov 12 2014
    Q3 2014 MELA Sciences Earnings Release - Time Not Supplied Nov 12 2014
    MELA Sciences to Report Third Quarter 2014 Financial Results on Wednesday, November 12 Nov 05 2014
    Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for... Oct 22 2014
    Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for... Oct 21 2014
    MELA Sciences to Provide Corporate Overview at the Craig-Hallum Capital Group's 2014 Alpha Select... Sep 15 2014
    MELA Sciences to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment... Sep 08 2014
    MELA Sciences Collaborates With Columbia University Imaging Experts Aug 26 2014
    MELA SCIENCES, INC. /NY Financials Aug 23 2014
    UPDATE: H.C. Wainwright & Co. Initiates Coverage On MELA Sciences On Commercialization Strategy... Aug 18 2014
    MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report Aug 14 2014
    MELA Sciences Inc Earnings Call scheduled for 4:30 pm ET today Aug 13 2014
    MELA SCIENCES, INC. /NY Files SEC form 8-K, Financial Statements and Exhibits Aug 06 2014
    MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 29 2014
    MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Jul 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK